U.S. Aerospace & Defense Stock News

Analysts expect HealthEquity (HQY) to report quarterly earnings of $1.19 per share and revenue of $350.23 million in its upcoming release, with projections indicating growth in custodial revenue and total HSA assets. See our latest analysis for HealthEquity. HealthEquity’s recent momentum has been firm, with a 30-day share price return of 11.38% and a 90-day share price return of 20.80%. The 1-year total shareholder return of 20.57% highlights how expectations around earnings and HSA growth...

NeoGenomics, Inc. previously announced that Alicia Olivo, EVP, General Counsel & Business Development, would step down as General Counsel in September 2026 and remain with the company until early October 2026 to support the transition. The company also secured a favorable North Carolina court ruling that invalidated key Natera patents, reducing legal friction around its RaDaR ST assay and altering the competitive landscape in molecular residual disease testing. We’ll now examine how this...

CDW stock has fallen about 33.0% over the past three years, yet the current share price of US$132.51 still screens as cheap on both an intrinsic value estimate using a Discounted Cash Flow (DCF) approach and on earnings based multiples. That combination of weak recent returns and supportive valuation signals is what investors are weighing today. CDW's share price has declined 33.0% over three years, which puts the focus on whether the market has become too pessimistic about the company’s...

Energy sensitive inflation is back in focus as oil and gas prices feed into policy debates and consumer budgets. That spotlight on security and supply puts Aerospace and Defense stocks on many watchlists, since governments tend to treat defense and critical infrastructure as priority spending. This article explains why that theme matters now and highlights 3 Aerospace and Defense screener picks worth a closer look. The 3 Aerospace and Defense stocks below are just a sample. The full screen...

Avery Dennison (AVY) has drawn fresh attention after the Board elected William Wagner as independent Board Chair, effective September 1, 2026. This marks a planned shift in its long term leadership structure. See our latest analysis for Avery Dennison. The recent Board succession news lands after a period where Avery Dennison’s share price has gained momentum, with a 7 day share price return of 4.0% and a 30 day share price return of 14.16%, while the 1 year total shareholder return of 6.87%...

Earlier in August 2026, Unifor reached tentative three-year labour agreements with General Motors covering more than 4,600 workers across key Canadian plants, while U.S.–Canada tensions intensified after President Trump announced plans for 50% tariffs on Canadian auto and parts imports starting January 1, 2027. At the same time, GM’s role in backing EVgo’s expanding fast‑charging network highlights how its long-term EV infrastructure commitments sit alongside rising cost uncertainty from...

MercadoLibre (MELI) is back in focus after reporting a 39% year over year jump in Brazil gross merchandise volume, driven by stronger buyer engagement, more active sellers, and user growth tied to free shipping and payment incentives. See our latest analysis for MercadoLibre. At a share price of $1,947.90, MercadoLibre has seen strong short term momentum with a 7 day share price return of 8.97% and a 90 day share price return of 18.19%. The 1 year total shareholder return is down 19.10% but...

Immunome (IMNM) reported second quarter 2026 results that showed a wider loss, which may be influencing how investors view the stock following the announcement earlier in August 2026. See our latest analysis for Immunome. At a share price of US$28.01, Immunome has seen a 26.11% 1-month share price return and a 34.53% year-to-date share price return, alongside a 1-year total shareholder return of 182.36%. This suggests that recent earnings news is being weighed against a much stronger...

In recent days, Fannie Mae has seen another wave of senior executive departures and cut about a dozen top leaders, while a white paper from Oksenholt Capital Management proposed a new public holding company that would sit above both Fannie Mae and Freddie Mac to capture operational and technology synergies. These management changes and structural proposals raise fresh questions about executive stability, multifamily financing capacity, and how Fannie Mae’s federal charter might be positioned...

Birkenstock Holding (BIRK) moved back into focus after reporting stronger third quarter revenues, raising full-year revenue and adjusted EBITDA guidance, and pairing those updates with an accelerated share repurchase program. See our latest analysis for Birkenstock Holding. Despite the improved guidance and active capital management, Birkenstock Holding’s recent share price return has been weak, with the stock down 13.12% over 30 days and the 1 year total shareholder return declining 32.94%,...

IPG Photonics (IPGP) has drawn fresh attention after a recent pullback in its share price, with the stock closing at $70.74. Investors are reassessing the laser specialist as its recent returns show persistent weakness. See our latest analysis for IPG Photonics. The recent 1 day share price return of down 3.44% extends a sharp reset, with the 30 day share price return down 22.86% and the 1 year total shareholder return down 13.43%. This points to fading momentum as investors reassess IPG...

Earlier this year, Cheesecake Factory gained a Zacks Rank of #1 (Strong Buy) as analysts raised full‑year earnings estimates by 11.6%, signaling stronger expected profitability. What stands out is how rapidly improving analyst sentiment and upgraded earnings forecasts have repositioned Cheesecake Factory within the Retail‑Wholesale group. We’ll now explore how this upgraded analyst outlook, including higher full‑year earnings estimates, could reshape Cheesecake Factory’s investment...

BeOne Medicines (NasdaqGS:ONC) received FDA approval for TEVIMBRA (tislelizumab) plus ZIIHERA (zanidatamab) and chemotherapy as a first-line treatment for unresectable or metastatic HER2-positive gastric, gastroesophageal junction, or esophageal adenocarcinoma. The newly approved regimen is described as the first and only immunotherapy-based option to deliver more than two years of median overall survival in first-line HER2+ GEA. This decision adds a new US indication for BeOne Medicines and...

Ameren dividend declaration and what it means for shareholders Ameren (AEE) has affirmed its income policy, with the board declaring a quarterly cash dividend of $0.75 per share, payable September 30, 2026, to shareholders of record on September 8, 2026. See our latest analysis for Ameren. Ameren shares trade at $107.16, with a 1-day share price return of 0.97% and a year-to-date share price return of 6.25%. The 3-year total shareholder return of 46.36% points to stronger longer term...

CoreWeave (NasdaqGS:CRWV) expanded its AI cloud ecosystem, becoming a key infrastructure provider within Rescale's digital engineering cloud for next generation R&D. The company also entered a multi year agreement with Hudson River Trading to supply AI cloud resources for quantitative trading research. These partnerships connect CoreWeave to demanding AI and high performance computing workloads across both engineering and financial markets. For readers looking to explore more companies...

Tapestry (TPR) stock is in focus after the company reported fourth quarter and full year results, which showed higher sales and a swing to profit, alongside a 16% dividend increase and completion of a large buyback. See our latest analysis for Tapestry. The recent earnings, dividend increase and completed buyback have kept Tapestry in focus, with the 1 day share price return of 1.53% lifting the stock to US$132.16 even as the 30 day share price return is down 7.32%. That sits against a 1 year...

SpaceX’s plan to pour up to US$100b into a new Starship launch hub in Louisiana has suddenly made space infrastructure feel much more real for investors. A project built around thousands of potential launches and 10,000 jobs can ripple across suppliers, satellite operators and ground systems. This article explores three stocks that appear positively tied to that story so you can judge where the opportunity or risk might sit for your portfolio. The three stocks in this article are just a...

GE HealthCare Technologies (NasdaqGS:GEHC) named William K. Grogan as its next Chief Financial Officer, effective 14 September 2026. Grogan previously held senior finance roles at Xylem Inc. and IDEX Corporation, where he oversaw portfolio repositioning and large acquisition integrations. The CFO transition represents a key leadership shift for GE HealthCare, with potential implications for capital deployment and operational efficiency. For readers interested in more ideas in this area, the...

In August 2026, TScan Therapeutics disclosed that Amgen elected to terminate their May 2023 Research Collaboration and License Agreement focused on Crohn's disease, effective November 10, 2026, with no early termination penalty and the wind-down of current research activities. The move ends Amgen's exclusive rights to develop and commercialize any Crohn's disease product candidates from TScan's T-cell target discovery platform, removing potential success-based milestones of over US$500.00...

V.F stock has fallen sharply over the past five years, yet the current market price of US$14.31 sits at a discount to what both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples suggest the business may be worth. V.F shareholders have seen the share price decline about 78.0% over five years, which keeps expectations low despite a recent 6.9% gain over the past year. If the company can stabilise cash flows and improve profitability, that can support the intrinsic...

ServiceNow (NOW) is back in focus after a series of AI centric announcements, including an expanded partnership with Tech Mahindra, new alliances with CoreX and Tribal, and fresh attention from Wall Street analysts. See our latest analysis for ServiceNow. ServiceNow’s recent AI partnerships and product traction have arrived alongside a sharp 30 day share price return of 29.63% and a 90 day share price return of 28.15%, although the year to date share price return is down 13.16% and the 1 year...

Earlier this week, Zoom Communications (NASDAQ: ZM) reported quarterly results, with attention centering on its earnings performance and commentary around AI initiatives. A particular focus was Zoom’s US$51 million stake in AI firm Anthropic, which analysts suggest could materially influence how investors view the company’s long-term value drivers. Next, we’ll examine how Zoom’s Anthropic investment interacts with its AI-first platform ambitions and what this means for the existing...

Earlier this month, Arista Networks reported its first quarter above US$3,000,000,000 in revenue with a 45% operating margin, raised its full-year 2026 guidance, and disclosed that multiyear purchase commitments had grown to US$9.70 billion from US$3.60 billion a year earlier. These results, supported by strong AI infrastructure demand and the Arista 2.0 platform strategy, underline how central high-performance networking has become to modern data centers. We’ll now examine how Arista’s...

Palo Alto Networks stock has delivered a very large 5 year gain, yet the latest valuation checks suggest the shares are not a clear bargain, with the intrinsic value estimate looking roughly in line with the market price while market based multiples lean expensive. Palo Alto Networks has returned about 3.6x over 5 years, which puts extra focus on whether the current price still leaves room for attractive long term returns. Recent alliances around AI focused cybersecurity, such as the...